Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 762820, 12 pages
http://dx.doi.org/10.1155/2015/762820
Research Article

Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis

Department of Endocrinology and Metabolism, The Endocrine Institute and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China

Received 20 August 2015; Revised 20 October 2015; Accepted 25 October 2015

Academic Editor: Lorenzo Cavagna

Copyright © 2015 Rui Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Sinha, S. N. Singh, and U. S. Ray, “Total antioxidant status at high altitude in lowlanders and native highlanders: role of uric acid,” High Altitude Medicine and Biology, vol. 10, no. 3, pp. 269–270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Li, W. Hou, X. Zhang, L. Hu, and Z. Tang, “Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies,” Atherosclerosis, vol. 232, no. 2, pp. 265–270, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Liu, T. Wang, H. N. Zhao et al., “The prevalence of hyperuricemia in China: a meta-analysis,” BMC Public Health, vol. 11, article 832, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Nakanishi, M. Okamoto, H. Yoshida, Y. Matsuo, K. Suzuki, and K. Tatara, “Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers,” European Journal of Epidemiology, vol. 18, no. 6, pp. 523–530, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. Johnson, D.-H. Kang, D. Feig et al., “Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?” Hypertension, vol. 41, no. 6, pp. 1183–1190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Wang, T. Qin, J. Chen et al., “Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies,” PLoS ONE, vol. 9, no. 12, Article ID e114259, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Bos, P. J. Koudstaal, A. Hofman, J. C. M. Witteman, and M. M. B. Breteler, “Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study,” Stroke, vol. 37, no. 6, pp. 1503–1507, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. T.-C. Peng, C.-C. Wang, T.-W. Kao et al., “Relationship between hyperuricemia and lipid profiles in US adults,” BioMed Research International, vol. 2015, Article ID 127596, 7 pages, 2015. View at Publisher · View at Google Scholar
  9. H.-Y. Chang, C.-W. Tung, P.-H. Lee et al., “Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population,” American Journal of the Medical Sciences, vol. 339, no. 6, pp. 509–515, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. D. I. Feig, D.-H. Kang, and R. J. Johnson, “Uric acid and cardiovascular risk,” The New England Journal of Medicine, vol. 359, no. 17, pp. 1811–1821, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Grassi, G. Desideri, A. V. Di Giacomantonio, P. Di Giosia, and C. Ferri, “Hyperuricemia and cardiovascular risk,” High Blood Pressure and Cardiovascular Prevention, vol. 21, no. 4, pp. 235–242, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Huang, B. Huang, Y. Li et al., “Uric acid and risk of heart failure: a systematic review and meta-analysis,” European Journal of Heart Failure, vol. 16, no. 1, pp. 15–24, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. L. C. Soriano, D. Rothenbacher, H. K. Choi, and L. A. García, “Contemporary epidemiology of gout in the UK general population,” Arthritis Research and Therapy, vol. 13, no. 2, article R39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. H. K. Choi, D. B. Mount, and A. M. Reginato, “Pathogenesis of gout,” Annals of Internal Medicine, vol. 143, no. 7, pp. 499–516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. J. Luk and P. A. Simkin, “Epidemiology of hyperuricemia and gout,” American Journal of Managed Care, vol. 11, no. 15, supplement, pp. S435–S442, 2005. View at Google Scholar · View at Scopus
  16. H. K. Choi, E. S. Ford, C. Li, and G. Curhan, “Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey,” Arthritis Care and Research, vol. 57, no. 1, pp. 109–115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Annemans, E. Spaepen, M. Gaskin et al., “Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005,” Annals of the Rheumatic Diseases, vol. 67, no. 7, pp. 960–966, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Arromdee, C. J. Michet, C. S. Crowson, W. M. O'Fallon, and S. E. Gabriel, “Epidemiology of gout: is the incidence rising?” Journal of Rheumatology, vol. 29, no. 11, pp. 2403–2406, 2002. View at Google Scholar · View at Scopus
  19. G. Trifirò, P. Morabito, L. Cavagna et al., “Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study,” Annals of the Rheumatic Diseases, vol. 72, no. 5, pp. 694–700, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Klemp, S. A. Stansfield, B. Castle, and M. C. Robertson, “Gout is on the increase in New Zealand,” Annals of the Rheumatic Diseases, vol. 56, no. 1, pp. 22–26, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Zhu, B. J. Pandya, and H. K. Choi, “Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008,” Arthritis and Rheumatism, vol. 63, no. 10, pp. 3136–3141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. E. Hak and H. K. Choi, “Lifestyle and gout,” Current Opinion in Rheumatology, vol. 20, no. 2, pp. 179–186, 2008. View at Publisher · View at Google Scholar
  23. F. Zhai, Y. He, G. Ma et al., “Study on the current status and trend of food consumption among Chinese population,” Chinese Journal of Epidemiology, vol. 26, no. 7, pp. 485–488, 2005 (Chinese). View at Google Scholar
  24. S. L. Wallace, H. Robinson, A. T. Masi, J. L. Decker, D. J. McCarty, and T. F. Yü, “Preliminary criteria for the classification of the acute arthritis of primary gout,” Arthritis and Rheumatism, vol. 20, no. 3, pp. 895–900, 1977. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Roubenoff, “Gout and hyperuricemia,” Rheumatic Disease Clinics of North America, vol. 16, no. 3, pp. 539–550, 1990. View at Google Scholar · View at Scopus
  26. C. Han, X. He, X. Xia et al., “Subclinical hypothyroidism and type 2 diabetes: a systematic review and meta-analysis,” PLoS ONE, vol. 10, no. 8, Article ID e0135233, 2015. View at Publisher · View at Google Scholar
  27. J. P. T. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, “Measuring inconsistency in meta-analyses,” British Medical Journal, vol. 327, no. 7414, pp. 557–560, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Zhao, C. Han, X. Shi et al., “Prevalence of goiter and thyroid nodules before and after implementation of the Universal Salt Iodization program in mainland China from 1985 to 2014: a systematic review and meta-analysis,” PLoS ONE, vol. 9, no. 10, Article ID e109549, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Shi, P. Du, X. An et al., “Analysis of the relationship between serum uric acid levels and chronic diseases among residents in Shijingshan district, Beijing,” Capital Journal of Public Health, vol. 7, no. 4, pp. 159–163, 2013 (Chinese). View at Google Scholar
  30. P. Ma, L. Chen, and P. Yang, “The correlation between hyperuricemia and metabolic syndrome in the residents in Xicheng district of Beijing,” Tianjin Medical Journal, vol. 42, no. 7, pp. 722–724, 2014 (Chinese). View at Google Scholar
  31. D. Li, M. Ma, Y. Su et al., “The prevalence of hyperuricemia of bortala residents and its influencing factors,” Modern Preventive Medicin, vol. 40, no. 9, pp. 1746–1748, 2013 (Chinese). View at Google Scholar
  32. J. Zheng, P. Chen, and J. Xie, “Analysis on prevalence rate and influential factors of hyperuricemia among residents in Ouhai District, Wenzhou,” Zhejiang Preventive Medicine, vol. 22, no. 12, pp. 13–16, 2010 (Chinese). View at Google Scholar
  33. X. Sun, X. Wang, X. Pan et al., “Investigation of the prevalence and distributing feature of cardiovascular disease risk factors in Zhangzi island of Dalian,” Chinese Journal of Cardiovascular Medicine, vol. 13, no. 4, pp. 280–283, 2008 (Chinese). View at Google Scholar
  34. G. Hou, L. Luo, L. Cheng, and Z. Gao, “Analysis on prevalence and influence factors of hyperuricemia among residents in Dalian Zhangzidao,” The Journal of Medical Research, vol. 39, no. 2, pp. 37–40, 2010 (Chinese). View at Google Scholar
  35. R. Wang, “Analysis of urinary calculi in patients with hyperuricemia,” Journal of Taishan Medical College, vol. 31, no. 4, pp. 300–301, 2010 (Chinese). View at Google Scholar
  36. J. W. Yu, T. G. Yang, W. X. Diao et al., “Epidemiological study on hyperuricemia and gout in Foshan areas, Guangdong province,” Chinese Journal of Epidemiology, vol. 31, no. 8, pp. 860–862, 2010 (Chinese). View at Google Scholar
  37. W. Wu, J. Guo, W. Yang, Z. Zhong, Y. Liu, and H. Luo, “Epidemiology of hyperuricemia and gout in a community in Guangzhou,” Chinese Journal of General Practice, vol. 6, no. 7, pp. 728–729, 2008 (Chinese). View at Google Scholar
  38. G. Zou, Y. Xiang, W. Che et al., “Prevalence of hyperuricemia in community residents of Xiangshan Disteict, Guilin City,” Chinese Journal of Hypertension, vol. 19, no. 2, pp. 148–152, 2011 (Chinese). View at Google Scholar
  39. L. Wang, H. Fu, Y. Sun, and W. Cai, “A survey of metabolic syndrome and its related diseases in fishing village in island,” Zhejiang Preventive Medicine, vol. 20, no. 10, pp. 8–9, 2008 (Chinese). View at Google Scholar
  40. J. Meng, Y. Zhu, W. Tan et al., “Prevalence of hyperuricemia in rural residents of Gaoyou City, Jiangsu Province,” Chinese Journal of Rheumatology, vol. 16, no. 7, pp. 436–441, 2012. View at Google Scholar
  41. S. Shen, H. Li, Y. Feng et al., “Correlation between serum uric acid and metabolic syndrome of adults in Suxichang area of Jiangsu province,” Chinese Journal of Prevention and Control of Chronic Diseases, vol. 22, no. 1, pp. 39–42, 2014 (Chinese). View at Google Scholar
  42. W. Song, J. Liu, Z. Chen, Y. Huo, A. Lin, and Y. Zhang, “Hyperuricemia and gout: a prevalence survey among over-40-year-old community residents in Nanchang District,” Chinese General Practice, vol. 17, no. 2, pp. 181–185, 2014 (Chinese). View at Google Scholar
  43. J. Shao, B. Mo, R. Yu, Z. Li, H. Li, and Y. Xu, “Epidemiological study on hyperuricemia and gout in community of Nanjing,” Chinese Journal of Disease Control and Prevention, vol. 7, no. 4, pp. 305–308, 2003 (Chinese). View at Google Scholar
  44. F. Zhou, Q. Luo, L. Wu et al., “Epidemiological survey of chronic kidney disease among adults in Ningbo,” Chinese Journal of Preventive Medicine, vol. 14, no. 9, pp. 669–674, 2013 (Chinese). View at Google Scholar
  45. J. Huang, B. Zhou, S. Chen, and J. Dong, “A cross-sectional study on gout and hyperuricemia in community population,” Zhejiang Journal of Preventive Medicine, vol. 25, no. 7, pp. 8–10, 2013 (Chinese). View at Google Scholar
  46. H. Xin, Q. Cao, F. Zhao et al., “Analysis on blood glucose, and blood lipid test results between hyperuricemia people and the general population,” Preventive Medicine Tribune, vol. 17, no. 13, pp. 171–177, 2013 (Chinese). View at Google Scholar
  47. X. Tian, Z. Pang, G. Bao et al., “Ananlysis on prevalence and influence factors of hyperuricemia among residents in Qingdao,” Chinese Journal of Public Health, vol. 24, no. 3, pp. 360–362, 2008 (Chinese). View at Google Scholar
  48. Y. Dong, H. Nan, and W. Gao, “Prevalence of the metabolic syndrome among adults aged 20–74 years in Zhanshan community of Qingdao,” Chinese Journal of Diabetes, vol. 12, no. 2, pp. 177–181, 2004 (Chinese). View at Google Scholar
  49. X. Zhang, W. Yu, L. Yu, L. Zhang, and Y. Yu, “An epidemiologic study on hyperuricaemia and gout in risidents of coastal areas of Haiyang City in Shangdong,” Chinese Journal of General Practitioners, vol. 5, no. 4, pp. 216–219, 2006 (Chinese). View at Google Scholar
  50. X. Wang, “Analysis on prevalence and correlative factors of hyperuricemia among residents in Shenyang,” in Proceedings of the 9th Annual Meeting of Chinese Society of Endocrinology, p. 46, 2010 (Chinese).
  51. X. Chen, Y. Zou, G. Li, Y. Xiao, and L. Wang, “Analysis on prevalence and influence factors of hyperuricemia among residents in Sichuan,” Sichuan Medical Journal, vol. 29, no. 9, pp. 1267–1269, 2008 (Chinese). View at Google Scholar
  52. W. Guo, C. Xiao, X. Shen, G. Liu, and H. Zhang, “Prevalence of hyperuricemia and its relationship to hypertension, hyperglycemia and hyperlipidemia in community residents in Taiyuan city,” Chinese Jeneral Practice, vol. 15, no. 9, pp. 3045–3047, 2012 (Chinese). View at Google Scholar
  53. J. Wang, Y. Shao, Y. Chen, H. Qian, and N. Zhang, “Analysis on Wenzhou citizen's hyperuricemia and the influence factor,” Chinese Journal of Health Laboratory Technology, vol. 20, no. 10, pp. 2545–2547, 2010 (Chinese). View at Google Scholar
  54. Y. Shao, “Risk investigation on hyperuricemia among residents of two communities in Wenzhou City,” Shanghai Journal of Preventive Medicine, vol. 23, no. 6, pp. 257–260, 2011 (Chinese). View at Google Scholar
  55. Y. Pan, D. Qiang, J. Ding, and Y. Shen, “Analysis on prevalencing of hyperuricemia and influence factors in Wujin District,” Chinese Journal of Prevention and Control of Chronic Non-Communicable Disease, vol. 22, no. 3, pp. 315–317, 2014 (Chinese). View at Google Scholar
  56. W. Duan, J. Zhang, Y. Ma, and J. Cheng, “Prevalence and influencing factors of hyperuricemia among residents in Korla Region of Xinjiang,” Chinese Jeneral Practice B, vol. 16, no. 3, 2013 (Chinese). View at Google Scholar
  57. P. Zhang, L. Zhang, C. Wang, S. Wei, and Q. Qiao, “Epidemiology of hyperuricemia and gout in Xingtai among adults over 30 years old,” Practical Preventive Medicine, vol. 21, no. 8, pp. 1010–1012, 2014. View at Google Scholar
  58. S. Mou, C. Lv, J. Ju, Y. He, P. Guang, and Y. Ying, “Analusis of hyperuricemia of urban peasants,” Chinese Primarhy Health Care, vol. 27, no. 6, pp. 66–67, 2013 (Chinese). View at Google Scholar
  59. S. Li, J. Yu, S. Lv, and Y. Zhang, “The prevalence and risk bactors of hyperuricaemia in Yan'an,” Chinese Journal of Preventive Medicine, vol. 11, no. 8, pp. 763–765, 2010 (Chinese). View at Google Scholar
  60. X. Chen, H. Yang, and J. Yang, “Prevalence of hyperuricemia and gout among residents in Dali, Yunnan,” China Practical Medical, vol. 4, no. 10, pp. 257–259, 2009 (Chinese). View at Google Scholar
  61. L. Jin, Y. Ma, R. Huang, J. Chen, H. Xiao, and X. Chen, “Epidemiology of hyperuricemia and influence factors among rural residents in Doumen District, Zhuhai,” Chinese Community Doctors, vol. 11, no. 20, pp. 254–255, 2009 (Chinese). View at Google Scholar
  62. Z. Cai, X. Xu, X. Wu, C. Zhou, and D. Li, “Hyperuricemia and the metabolic syndrome in Hangzhou,” Asia Pacific Journal of Clinical Nutrition, vol. 18, no. 1, pp. 81–87, 2009. View at Google Scholar · View at Scopus
  63. L. You, A. Liu, G. Wuyun, H. Wu, and P. Wang, “Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area,” Journal of Atherosclerosis and Thrombosis, vol. 21, no. 4, pp. 355–365, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. Q. Zhang, S. Lou, Z. Meng, and X. Ren, “Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome in Chinese,” Clinical Rheumatology, vol. 30, no. 6, pp. 777–787, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. S. R. Bapoje, A. Bahia, J. E. Hokanson et al., “Effects of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with left ventricular systolic dysfunction: a meta-analysis of randomized controlled trials,” Circulation: Heart Failure, vol. 6, no. 2, pp. 166–173, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Uaratanawong, S. Suraamornkul, S. Angkeaw, and R. Uaratanawong, “Prevalence of hyperuricemia in Bangkok population,” Clinical Rheumatology, vol. 30, no. 7, pp. 887–893, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. K. Nagahama, K. Iseki, T. Inoue, T. Touma, Y. Ikemiya, and S. Takishita, “Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan,” Hypertension Research, vol. 27, no. 4, pp. 227–233, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. V. Lohsoonthorn, B. Dhanamun, and M. A. Williams, “Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams,” Archives of Medical Research, vol. 37, no. 7, pp. 883–889, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. I. Sari, S. Akar, B. Pakoz et al., “Hyperuricemia and its related factors in an urban population, Izmir, Turkey,” Rheumatology International, vol. 29, no. 8, pp. 869–874, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. S.-Y. Chuang, S.-C. Lee, Y.-T. Hsieh, and W.-H. Pan, “Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993–1996 to 2005–2008,” Asia Pacific Journal of Clinical Nutrition, vol. 20, no. 2, pp. 301–308, 2011. View at Google Scholar · View at Scopus
  71. L. Zhang, F. Wang, L. Wang et al., “Prevalence of chronic kidney disease in China: a cross-sectional survey,” The Lancet, vol. 379, no. 9818, pp. 815–822, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Bardin, S. Bouee, P. Clerson et al., “Prevalence of gout in the adult population of France,” Arthritis Care & Research, 2015. View at Publisher · View at Google Scholar
  73. M. Birlik, O. Gurler, S. Akar, I. Sari, F. Onen, and N. Akkoc, “The prevalence of gout in an urban area of Izmir, Turkey: a population-based epidemiological study,” International Journal of Clinical Practice, vol. 68, no. 6, pp. 775–782, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Rodriguez-Amado, I. Peláez-Ballestas, L. H. Sanin et al., “Epidemiology of rheumatic diseases. A community-based study in urban and rural populations in the state of Nuevo Leon, Mexico,” Journal of Rheumatology, vol. 38, no. 86, pp. 9–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Andrianakos, P. Trontzas, F. Christoyannis et al., “Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study, The ESORDIG Study,” Journal of Rheumatology, vol. 30, no. 7, pp. 1589–1601, 2003. View at Google Scholar · View at Scopus
  76. P. Hanova, K. Pavelka, C. Dosta, I. Holcatova, and H. Pikhart, “Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003,” Clinical & Experimental Rheumatology, vol. 24, no. 5, pp. 499–507, 2006. View at Google Scholar · View at Scopus
  77. D. Winnard, C. Wright, W. J. Taylor et al., “National prevalence of gout derived from administrative health data in aotearoa New Zealand,” Rheumatology, vol. 51, no. 5, pp. 901–909, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. P. C. Robinson, W. J. Taylor, and T. R. Merriman, “Systematic review of the prevalence of gout and hyperuricaemia in Australia,” Internal Medicine Journal, vol. 42, no. 9, pp. 997–1007, 2012. View at Google Scholar · View at Scopus
  79. M. Ghei, M. Mihailescu, and D. Levinson, “Pathogenesis of hyperuricemia: recent advances,” Current Rheumatology Reports, vol. 4, no. 3, pp. 270–274, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. H. K. Choi, “A prescription for lifestyle change in patients with hyperuricemia and gout,” Current Opinion in Rheumatology, vol. 22, no. 2, pp. 165–172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. H. K. Choi, X. Gao, and G. Curhan, “Vitamin C intake and the risk of gout in men: a prospective study,” Archives of Internal Medicine, vol. 169, no. 5, pp. 502–507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. J. M. A. Wijnands, A. Boonen, I. C. W. Arts, P. C. Dagnelie, C. D. A. Stehouwer, and S. van der Linden, “Large epidemiologic studies of gout: challenges in diagnosis and diagnostic criteria,” Current Rheumatology Reports, vol. 13, no. 2, pp. 167–174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. W. J. Taylor, J. Fransen, N. Dalbeth et al., “Performance of classification criteria for gout in early and established disease,” Annals of the Rheumatic Diseases, 2014. View at Publisher · View at Google Scholar
  84. W. J. Taylor, J. Fransen, T. L. Jansen et al., “Study for updated gout classification criteria: identification of features to classify gout,” Arthritis Care & Research, vol. 67, no. 9, pp. 1304–1315, 2015. View at Publisher · View at Google Scholar
  85. T. Neogi, T. L. Jansen, N. Dalbeth et al., “2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative,” Annals of the Rheumatic Diseases, vol. 74, no. 10, pp. 1789–1798, 2015. View at Publisher · View at Google Scholar